103 related articles for article (PubMed ID: 9142455)
1. Susceptibility of Moraxella catarrhalis to 21 antimicrobial drugs: validity of current NCCLS criteria for the interpretation of agar disk diffusion antibiograms.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(3):159-67. PubMed ID: 9142455
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Enterococcus faecalis and E. faecium: comparison of Mueller-Hinton, Iso-Sensitest, and Wilkins-Chalgren agar media.
Traub WH; Geipel U; Leonhard B
Chemotherapy; 1998; 44(4):217-29. PubMed ID: 9681198
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
[TBL] [Abstract][Full Text] [Related]
4. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility testing (agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium.
Traub WH; Geipel U; Leonhard B; Bauer D
Chemotherapy; 1998; 44(4):230-7. PubMed ID: 9681199
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
Traub WH; Leonhard B
Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
[TBL] [Abstract][Full Text] [Related]
9. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
Yeo SF; Livermore DM
J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Jang TN; Liu CY; Lau YJ; Liu YC; Chuang YC; Lee N
J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(3):164-73. PubMed ID: 9612606
[TBL] [Abstract][Full Text] [Related]
12. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
[TBL] [Abstract][Full Text] [Related]
13. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents.
Doern GV; Tubert T
Antimicrob Agents Chemother; 1987 Oct; 31(10):1519-23. PubMed ID: 3124732
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
15. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
Ejlertsen T; Skov R
APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
[TBL] [Abstract][Full Text] [Related]
16. Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards.
Kibsey PC; Rennie RP; Rushton JE
J Clin Microbiol; 1994 Nov; 32(11):2786-90. PubMed ID: 7852573
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
Christensen JJ; Keiding J; Bruun B
APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
Mikucka A; Janicka G; Krawiecka D; Kochanowska J
Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis.
Wallace RJ; Nash DR; Steingrube VA
Am J Med; 1990 May; 88(5A):46S-50S. PubMed ID: 2111092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
